Cover Image

Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C

Interferon is used to treat hepatitis C virus infection and its cutaneous side effects are well known. Recently, interferon-induced sarcoidosis has been reported. We report a new case of sarcoidosis during pegylated interferon alfa and ribavirin treatment with an unusual presentation in a woman with...

Full description

Saved in:

Bibliographic Details
Main Authors:	R. Rodríguez-Lojo (Author), M. Almagro (Author), J. M. Barja (Author), F. Piñeyro (Author), L. Pérez-Varela (Author), J. Del Pozo (Author), M. T. Yebra-Pimentel (Author), E. Fonseca (Author)
Format:	Book
Published:	Hindawi Limited, 2010-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
by: Roberto J Carvalho-Filho, et al.
Published: (2010)

Pegylated Interferon (Alone or With Ribavirin) for Chronic Hepatitis C in Haemodialysis Population
by: Mario Espinosa, et al.
Published: (2015)

Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
by: Yasser K. Rashed, et al.
Published: (2020)

Psoriasis induced by Interferon alfa-2a and ribavirin in a patient followed for hepatitis C
by: N. Amraoui, et al.
Published: (2015)

Adverse Skin Reactions due to Ribavirin in Hepatitis C Combination Therapy with Pegylated Interferon-α2a
by: Masahisa Shindo, et al.
Published: (2013)

Prediction of sustained virologic responses to combination therapy of pegylated interferon-α and ribavirin in patients with chronic hepatitis C infection
by: Mona H Ismail
Published: (2013)

Pegylated interferon 2a and 2b in combination with ribavirin for the treatment of chronic hepatitis C in HIV infected patients
by: Ravinder Dhillon, et al.
Published: (2008)

Sarcoidosis with Both Plaques and Subcutaneous Nodules Associated with Combination Therapy with Peginterferon 𝜶-2a and Ribavirin
by: M. Kondo, et al.
Published: (2011)

Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers
by: Marisa Boff Costa, et al.
Published: (2018)

Simple score to predict risk of hepatocellular carcinoma in chronic hepatitis C patients with advanced fibrosis after pegylated interferon and ribavirin therapy
by: Hu CC, et al.
Published: (2018)

Seminal parameters before and during combined antiviral (pegylated interferon α-2a and ribavirin) treatment in chronic hepatitis C virus patients in upper Egypt
by: Hussein M Ghanem, et al.
Published: (2014)

Sustained virological response to treatment of chronic hepatitis C with peginterferon alfa and ribavirin
by: Junior André da Rosa, et al.
Published: (2012)

Polymorphism of IL-28B Gene (rs12979860) in HCV Genotype 1 Patients Treated by Pegylated Interferon and Ribavirin
by: Fahimeh Safarnezhad Tameshkel, et al.
Published: (2016)

PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE (SVR) TO PEGYLATED INTERFERON ALPHA (PEG-IFN α) AND RIBAVIRIN (RBV) IN PATIENTS WITH CHRONIC HEPATITIS C INFECTED WITH GENOTYPE 1.
by: Krasimir Antonov, et al.
Published: (2011)

Long-term surveillance of liver histological changes in chronic hepatitis C patients completing pegylated interferon-α plus ribavirin therapy: an observational cohort study
by: Ming-Han Hsieh, et al.
Published: (2022)

Subcutaneous Sarcoidosis
by: Sarkar J N, et al.
Published: (1998)

Efficacy of daclatasvir plus peginterferon alfa and ribavirin for patients with chronic hepatitis C genotype 4 infection
by: Hussien Ahmed, et al.
Published: (2017)

Clinical Evaluation of Terap C Vaccine in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis C
by: Dorta Guridi Zaily, MD, PhD, MS, PM, et al.
Published: (2017)

Cost-effectiveness of Oral Protease Inhibitors Co-administration versus Pegylated Interferon-Α2b and Ribavirin Only for the Patients with Hepatitis C Genotype 1 in Kazakhstan Health Care Settings
by: Alima ALMADIYEVA, et al.
Published: (2018)

Pegylated Interferon Associated Thyroidal Dysfunction Among Hepatitis C Patients
by: Nida Sajid, et al.
Published: (2024)

[Translated article] Dactylitis Due to Subcutaneous Sarcoidosis as a Manifestation of Sarcoidosis
by: J. Marcoval, et al.
Published: (2023)

Erythema annulare centrifugum-like eruption associated with pegylated interferon treatment for hepatitis C
by: Mark Naccarato, et al.
Published: (2013)

Erosive oral lichen planus after pegylated-interferon therapy for chronic hepatitis B
by: Ellie Choi, MMed, MRCP, et al.
Published: (2018)

Frequency Of Depressive And Anxiety Symptoms Among Patients On Interferon And Pegylated Interferon
by: Muhammad Waseem Shaikh, et al.
Published: (2024)

Borderline tuberculoid leprosy and type 1 leprosy reaction in a hepatitis C patient during treatment with interferon and ribavirin
by: Mônica Santos, et al.
Published: (2013)

Treatment of acute hepatitis C virus infection with interferon-α 2b and ribavirin: Case report and review of the literature
by: Sunbul Mustafa, et al.
Published: (2002)

Systematic review and meta-analysis: de novo combination of nucleos(t)ide analogs and pegylated interferon alpha versus pegylated interferon alpha monotherapy for the functional cure of chronic hepatitis B
by: Na Wei, et al.
Published: (2024)

The Role of Hepatitis C Virus NS5A Region Mutation and SNP IL-28B of Host to Support Successful Pegylated Interferon and Ribavirin Treatment in Patients with HCV-HIV Coinfection: A Prospective Cohort Study
by: Juferdy Kurniawan, et al.
Published: (2019)

Revisão sistemática da eficácia do interferon alfa (convencional, peguilado) e lamivudina para o tratamento da hepatite crônica B Efficacy of interferon (conventional, pegylated) and lamivudine for treatment of chronic hepatitis B: a systematic review
by: Alessandra Maciel Almeida, et al.
Published: (2009)

Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy
by: Bassem Refaat, et al.
Published: (2015)

Eosinophilic Panniculitis and Insect Bite-Like Eruption in a Patient with Chronic Lymphocytic Leukaemia: A Spectrum of the Same Entity
by: R. Rodríguez-Lojo, et al.
Published: (2010)

Subcutaneous Sarcoidosis - A Case Report
by: Gangopadhyay Asok Kumar
Published: (1999)

Subcutaneous sarcoidosis with underlying intramuscular granuloma
by: Takenobu Ohashi, et al.
Published: (2015)

INTERSTICIAL PNEUMONITIS, CAUSED BY PEGYLATED INTERFERON ALFA-2A IN A 4 MONTHS CHILD WITH GIGANTIC KAPOSI'S HAEMANGIOEPITHELIOM AND KASABACH - MERRIT PHENOMENON: A CASE REPORT
by: S. S. Postnikov, et al.
Published: (2022)

Increased oral lichen planus in a chronic hepatitis patient associated with elevated transaminase levels before and after interferon/ribavirin therapy
by: Shin-Yu Lu, et al.
Published: (2009)

Is subcutaneous sarcoidosis a marker for systemic disease?
by: Kollipara Haritha, et al.
Published: (2022)

Subcutaneous sarcoidosis: A report of rare case
by: Ashwini Ningaraju, et al.
Published: (2023)

Toll-like receptors 7 and 8 mRNA in monocytes of Egyptian children with chronic hepatitis C infection genotype 4 as predictor to "response" interferon and ribavirin treatment
by: Mohammed A. Khedr, et al.
Published: (2016)

Comparison of peginterferon alfa-2a and alfa-2b for treatment of patients with chronic hepatitis C:a retrospective study using the Japanese Interferon Database
by: Sato I, et al.
Published: (2014)

A Missense Variant in Granulysin is Associated with the Efficacy of Pegylated-Interferon-Alpha Therapy in Chinese Patients with HBeAg-Positive Chronic Hepatitis B
by: Li J, et al.
Published: (2021)